44 results Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare. Stibbe contributes to the Financial and Business Crime Global Guide Hans Van Bavel, Elisabeth Matthys and Ann Apers contributed to the Financial and Business Crime Global Guide. Temporary unemployment due to force majeure: extension of simplified procedures On 7 May, 2020, the ONEM/RVA has modified its instructions: the simplified procedures for temporary unemployment due to force majeure resulting from the Covid-19 crisis can be applied up to and including 30 June, 2020. Stibbe advises Blackstone Stibbe assisted Blackstone with the acquisition of Desotec. Stibbe advises the Antwerp Port Authority Stibbe advises the Antwerp Port Authority on its combination with the port of Zeebrugge. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby. Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Employment related questions with regard to the Coronavirus The Coronavirus has an immediate impact on the employment situation of companies and employees. We provide an overview on the most important questions in this regard. Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. How to cope with data protection rules in times of the coronavirus pandemic? Privacy issues are very pertinent in the fight against the coronavirus. Also in times of a global pandemic, general data protection restrictions must be respected. This section will focus on a number of considerations that can be taken into account. Stibbe announces new Counsel and Of Counsel appointments Brussels, 9 January 2020 – The Brussels office of Stibbe has promoted Delphine Gillet, Jan Proesmans and Sophie Bourgois to Counsel and Elisabeth Baeyens to Of Counsel. Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Pagination Current page 1 Page 2 Page 3 Next page
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Stibbe advises Avista Capital Partners Stibbe advised Avista Capital Partners in the acquistion of a 50% stake in Vision Healthcare.
Stibbe contributes to the Financial and Business Crime Global Guide Hans Van Bavel, Elisabeth Matthys and Ann Apers contributed to the Financial and Business Crime Global Guide.
Temporary unemployment due to force majeure: extension of simplified procedures On 7 May, 2020, the ONEM/RVA has modified its instructions: the simplified procedures for temporary unemployment due to force majeure resulting from the Covid-19 crisis can be applied up to and including 30 June, 2020.
Stibbe advises the Antwerp Port Authority Stibbe advises the Antwerp Port Authority on its combination with the port of Zeebrugge.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby.
Digital Law Up(to)date: No processing of vaccination status in recruitment process The Litigation Chamber of the Belgian DPA confirms that, in the absence of an existing legal basis, it is not possible for an employer, in this case a hospital, to make the recruitment of a person conditional on the fact that he/she has been vaccinated.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Employment related questions with regard to the Coronavirus The Coronavirus has an immediate impact on the employment situation of companies and employees. We provide an overview on the most important questions in this regard.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
How to cope with data protection rules in times of the coronavirus pandemic? Privacy issues are very pertinent in the fight against the coronavirus. Also in times of a global pandemic, general data protection restrictions must be respected. This section will focus on a number of considerations that can be taken into account.
Stibbe announces new Counsel and Of Counsel appointments Brussels, 9 January 2020 – The Brussels office of Stibbe has promoted Delphine Gillet, Jan Proesmans and Sophie Bourgois to Counsel and Elisabeth Baeyens to Of Counsel.
Stibbe advises Abry Partners and KORE Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.